Nyxoah to Participate in the Oppenheimer 33rd Annual Healthcare Conference
Nyxoah to Participate in the Oppenheimer 33rd Annual Healthcare Conference
Mont-Saint-Guibert, Belgium – March 7, 2023, 10:30pm CET / 4:30pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA), today announced that the Company will participate in the Oppenheimer 33rd Annual Healthcare Conference, which takes place March 13-15, 2023, virtually.
Olivier Taelman, Nyxoah’s Chief Executive Officer, will deliver a corporate update on Tuesday, March 14, 2023, at 11:20am ET. A webcast of the presentation will be available in the Events section of Nyxoah’s Investor Relations website. The Company will also be available for 1x1 meetings with institutional investors.
Nyxoah’s Investor Presentation can be accessed on the Shareholder Information section of the Company’s Investor Relations page.
About Nyxoah
Nyxoah is a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA). Nyxoah’s lead solution is the Genio® system, a patient-centered, leadless and battery-free hypoglossal neurostimulation therapy for OSA, the world’s most common sleep disordered breathing condition that is associated with increased mortality risk and cardiovascular comorbidities. Nyxoah is driven by the vision that OSA patients should enjoy restful nights and feel enabled to live their life to its fullest.
Following the successful completion of the BLAST OSA study, the Genio® system received its European CE Mark in 2019. Nyxoah completed two successful IPOs: on Euronext Brussels in September 2020 and NASDAQ in July 2021. Following the positive outcomes of the BETTER SLEEP study, Nyxoah received CE mark approval for the expansion of its therapeutic indications to Complete Concentric Collapse (CCC) patients, currently contraindicated in competitors’ therapy. Additionally, the Company is currently conducting the DREAM IDE pivotal study for FDA and U.S. commercialization approval.
For more information, please visit http://www.nyxoah.com/.
Caution – CE marked since 2019. Investigational device in the United States. Limited by U.S. federal law to investigational use in the United States.
Contact:
Nyxoah
David DeMartino, Chief Strategy Officer
david.demartino@nyxoah.com
+1 310 310 1313
Attachment
To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About GlobeNewswire by notified
GlobeNewswire by notifiedGlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.
Subscribe to releases from GlobeNewswire by notified
Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from GlobeNewswire by notified
New member proposed for election to the Board of Directors21.3.2023 14:38:36 CET | Press release
Company announcement no 6-2023 Copenhagen, March 21, 2023 New member proposed for election to the Board of Directors Konsolidator’s Board of Directors proposes that Peter Gath is elected as a new member of the Board of Directors at the company’s upcoming Annual General Meeting scheduled for 23 March 2023. Consequently, Konsolidator’s Board of Directors proposes that the company’s Board of Directors will consist of five members: the Chairman of the Board, Jesper Eigen Møller, and the members Thomas Aporta, Cecilia Hultén, Claus Jul Christiansen, and Peter Gath. Peter Gath enters the Board of Directors with over 20 years of experience as a partner from EY and KPMG. Peter is currently CFO of St. Jørgen Holding and holds multiple Board Member positions, incl. in the listed company Brødrene A & O Johansen A/S. As a Chartered Accountant with a background in audit and leadership, as well as an Adjunct Professor at Copenhagen Business School (CBS) and former Chairman of the Danish Institute of
SELIGSON & CO OMX HELSINKI 25 EXCHANGE TRADED FUND UCITS ETF: ANNUAL REPORT, BOARD OF THE MANAGEMENT COMPANY AND AUDITOR21.3.2023 14:30:00 CET | Press release
Seligson & Co Fund Management Company Plc STOCK EXCHANGE NOTICE 21 March 2023 SELIGSON & CO OMX HELSINKI 25 EXCHANGE TRADED FUND UCITS ETF: ANNUAL REPORT, BOARD OF THE MANAGEMENT COMPANY AND AUDITOR The Annual Report of Seligson & Co OMX Helsinki 25 Exchange Traded Fund UCITS ETF, dated 31 December 2022, has been published. The report, which is in Finnish, forms part (pages 41 to 47) of the attached common Annual Report for the Seligson & Co funds. The report and the Auditor's Report are also available at www.seligson.fi/sco/suomi/esitteet/. The following members were elected to the board of Seligson & Co Fund Management Company Plc at the Annual General Meeting held on 21 March 2023: Samu Anttila, Jarkko Niemi and Mikko Vasko. KPMG Plc was chosen as the auditor and CPA Marcus Tötterman as the deputy auditor. Further information: Mari Rautanen email: mari.rautanen@seligson.fi Phone +358 (0)9 6817 8224 Seligson & Co Fund Management Company Plc Ari Kaaro Managing Director email: ari.kaar
Ledende medarbejdere og disses nærtstående transaktioner.21.3.2023 14:09:36 CET | pressemeddelelse
Nasdaq Copenhagen Silkeborg, den 21. marts 2023 Fondsbørsmeddelelse nr. 2 / 2023 Vedr.: Ledende medarbejdere og disses nærtstående transaktioner. I henhold til Markedsmisbrugsforordningen art. 19 oplyser Silkeborg IF Invest A/S at have modtaget følgende meddelelse om erhvervelse af selskabets aktier: Navn: Silkeborg Fodbold Holding A/S Årsag: Silkeborg Fodbold Holding A/S ejes af Kent Villadsen Madsen, der er adm. direktør i Silkeborg IF Invest A/S. Udsteder: Silkeborg IF Invest A/S Fondskode: DK0010128008 Betegnelse: Aktie Transaktion: Køb Handelsdato: 20.03.2023 Marked: NASDAQ OMX Copenhagen A/S Antal: 10.000 stk. Kursværdi: 186.955,80 DKK. Eventuelle henvendelser vedr. nærværende fondsbørsmeddelelse bedes venligst rettet til undertegnede. Med venlig hilsen Silkeborg IF Invest A/S Kent Madsen Claus Christensen Adm. direktør Økonomidirektør Vedhæftet fil 2. Ledende medarbejdere og disses nærtstående transaktioner (20230321)
Fortinet Annual Skills Gap Report Uncovers an Increase in Breaches Attributed to a Lack of Cybersecurity Skills21.3.2023 14:00:00 CET | Press release
New Fortinet research reveals escalating cyber risks due to the ongoing talent shortage while the number of organizations experiencing five or more breaches jumped by 53% SUNNYVALE, Calif., March 21, 2023 (GLOBE NEWSWIRE) -- John Maddison, EVP of Products and CMO at Fortinet “The cybersecurity talent shortage is one of the top challenges putting organizations at risk, as clearly demonstrated by the results of the latest Global Cybersecurity Skills Gap Report from Fortinet. In today’s climate, organizations must choose products that introduce automation to offload overworked teams while continuing to focus on upskilling and cybersecurity training.” News Summary Fortinet® (NASDAQ: FTNT), the global cybersecurity leader driving the convergence of networking and security, today released its 2023 Global Cybersecurity Skills Gap Report, which reveals ongoing challenges related to the cybersecurity skills shortage affecting organizations worldwide. Key findings from the global report include:
INDKALDELSE TIL ORDINÆR GENERALFORSAMLING 202321.3.2023 13:41:17 CET | Press release
__________________________________________________________ INDKALDELSE TIL ORDINÆR GENERALFORSAMLING 2023 ERRIA A/S CVR-NR. 15300574 __________________________________________________________ Tidspunkt: onsdag, 12. april 2023 kl. 11:00 Sted: Duevang, Sankt Gertrudsstræde 2, 4600 Køge Bestyrelsen foreslår advokat Martin Skovbjerg, Bag Haverne 32, 4600 Køge, som dirigent. Dagsordenen er følgende: 1.Bestyrelsens beretning for selskabets virksomhed i det forløbne år.2.Forelæggelse af revideret årsrapport til godkendelse.3.Beslutning om anvendelse af overskud eller dækning af underskud i henhold til den godkendte årsrapport.Bestyrelsen indstiller, at årets resultat overføres til næste år. 4.Beslutning om decharge til bestyrelse og direktionen.Bestyrelsen indstiller, at der meddeles decharge til bestyrelsen og direktionen. 5.Valg af medlemmer til bestyrelsen.Følgende personer indstilles genvalgt til bestyrelsen: Søren Storgaard, Køge Kristian Svarrer, Esbjerg Ng Sing King, Singapore 6.Valg a